Pharmacy Practice in Focus: Health Systems July 2025 Volume 14 Issue 4 Semaglutide and Tirzepatide Lead the Way in Comprehensive Diabetes and Obesity Management Luke Halpern, Associate Editor Key Takeaways GLP-1 receptor agonists, like semaglutide, enhance diabetes care by improving glycemic control, weight loss, and reducing cardiovascular and renal risks
2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer
Ozempic also shows promise in heart health, safeguarding against risks in those with or prone to heart disease
GIP and GLP-1 have opposite effects on glucagon release with GIP stimulating glucagon release through an increase of intracellular cyclic adenosine monophosphate levels
You might be experiencing side effects that dont get better or your insurance might cover one and not another, for example
The 4 um thick paraffin sections were then dehydrated, stained with methylene blue, and washed with distilled water, followed by a repeat of dehydrating and washing the sections in order to prepare for a Nissl staining trial